[Therapeutic profile of haloperidol].
D000380:Agranulocytosis / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D003875:Drug Eruptions / Q000209:etiology; D004347:Drug Interactions; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D001523:Mental Disorders / Q000188:drug therapy*; D010640:Phenothiazines
D014150:Antipsychotic Agents; D010640:Phenothiazines; D006220:Haloperidol
Perfil terapéutico del haloperidol.